| Matthew Pinto, DO | |
|
33 Mitchell Ave, Binghamton, NY 13903 | |
| (607) 762-3281 | |
| (607) 762-3295 |
| Full Name | Matthew Pinto |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 9 Years |
| Location | 33 Mitchell Ave, Binghamton, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033506845 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 291611 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaleida Health | Buffalo, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Infinity Medical Group, P.c. | 0941598916 | 63 |
| Infinity Medical Of Wny Pc | 6507096922 | 44 |
News Archive
The American Jewish Committee urged the Egyptian government to allow a team of Israeli breast cancer researchers to enter the country for a major conference sponsored by Susan G. Komen for the Cure, a leading breast cancer awareness group based in the U.S. The Israeli team was denied entry into Egypt earlier this week, despite having previously received the necessary clearances to attend the conference in Alexandria.
The sensitivity of the GLP-1 hormone, which is secreted by the gastrointestinal tract, can predict the metabolic efficacy of a gastric bypass. The use of a GLP1 challenge could thus function as a novel predictive biomarker for personalized treatment of type 2 diabetes and obesity.
One in six women and one in twelve men in Austria suffers from some form of IBS - therefore around one million people in all. Using currently available techniques, it is only possible to diagnose IBS by a process of elimination.
Roark Capital Group, an Atlanta-based private equity firm, announced today that its affiliates have acquired Atkins Nutritionals, a leading international weight control and nutrition brand. Atkins' management team, led by CEO Monty Sharma, will remain with the business and invested alongside Roark Capital in the transaction. Terms of the transaction were not released.
New research by the Gladstone Institutes of Cardiovascular Disease (GICD) and the University of California, San Francisco (UCSF), has revealed the genetic determinants of fat storage in cells, which may lead to a new understanding of and potential treatments for obesity, diabetes, and heart disease. While scientists have long understood that lipid droplets contribute to fat build up in cells, the genes involved in droplet biology have been a focus of extensive research.
› Verified 6 days ago
| Entity Name | Infinity Medical Of Wny Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568883080 PECOS PAC ID: 6507096922 Enrollment ID: O20140305000476 |
News Archive
The American Jewish Committee urged the Egyptian government to allow a team of Israeli breast cancer researchers to enter the country for a major conference sponsored by Susan G. Komen for the Cure, a leading breast cancer awareness group based in the U.S. The Israeli team was denied entry into Egypt earlier this week, despite having previously received the necessary clearances to attend the conference in Alexandria.
The sensitivity of the GLP-1 hormone, which is secreted by the gastrointestinal tract, can predict the metabolic efficacy of a gastric bypass. The use of a GLP1 challenge could thus function as a novel predictive biomarker for personalized treatment of type 2 diabetes and obesity.
One in six women and one in twelve men in Austria suffers from some form of IBS - therefore around one million people in all. Using currently available techniques, it is only possible to diagnose IBS by a process of elimination.
Roark Capital Group, an Atlanta-based private equity firm, announced today that its affiliates have acquired Atkins Nutritionals, a leading international weight control and nutrition brand. Atkins' management team, led by CEO Monty Sharma, will remain with the business and invested alongside Roark Capital in the transaction. Terms of the transaction were not released.
New research by the Gladstone Institutes of Cardiovascular Disease (GICD) and the University of California, San Francisco (UCSF), has revealed the genetic determinants of fat storage in cells, which may lead to a new understanding of and potential treatments for obesity, diabetes, and heart disease. While scientists have long understood that lipid droplets contribute to fat build up in cells, the genes involved in droplet biology have been a focus of extensive research.
› Verified 6 days ago
| Entity Name | Infinity Medical Group, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841648011 PECOS PAC ID: 0941598916 Enrollment ID: O20161006000448 |
News Archive
The American Jewish Committee urged the Egyptian government to allow a team of Israeli breast cancer researchers to enter the country for a major conference sponsored by Susan G. Komen for the Cure, a leading breast cancer awareness group based in the U.S. The Israeli team was denied entry into Egypt earlier this week, despite having previously received the necessary clearances to attend the conference in Alexandria.
The sensitivity of the GLP-1 hormone, which is secreted by the gastrointestinal tract, can predict the metabolic efficacy of a gastric bypass. The use of a GLP1 challenge could thus function as a novel predictive biomarker for personalized treatment of type 2 diabetes and obesity.
One in six women and one in twelve men in Austria suffers from some form of IBS - therefore around one million people in all. Using currently available techniques, it is only possible to diagnose IBS by a process of elimination.
Roark Capital Group, an Atlanta-based private equity firm, announced today that its affiliates have acquired Atkins Nutritionals, a leading international weight control and nutrition brand. Atkins' management team, led by CEO Monty Sharma, will remain with the business and invested alongside Roark Capital in the transaction. Terms of the transaction were not released.
New research by the Gladstone Institutes of Cardiovascular Disease (GICD) and the University of California, San Francisco (UCSF), has revealed the genetic determinants of fat storage in cells, which may lead to a new understanding of and potential treatments for obesity, diabetes, and heart disease. While scientists have long understood that lipid droplets contribute to fat build up in cells, the genes involved in droplet biology have been a focus of extensive research.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Pinto, DO 359 Quaker Rd, East Aurora, NY 14052-2115 Ph: () - | Matthew Pinto, DO 33 Mitchell Ave, Binghamton, NY 13903 Ph: (607) 762-3281 |
News Archive
The American Jewish Committee urged the Egyptian government to allow a team of Israeli breast cancer researchers to enter the country for a major conference sponsored by Susan G. Komen for the Cure, a leading breast cancer awareness group based in the U.S. The Israeli team was denied entry into Egypt earlier this week, despite having previously received the necessary clearances to attend the conference in Alexandria.
The sensitivity of the GLP-1 hormone, which is secreted by the gastrointestinal tract, can predict the metabolic efficacy of a gastric bypass. The use of a GLP1 challenge could thus function as a novel predictive biomarker for personalized treatment of type 2 diabetes and obesity.
One in six women and one in twelve men in Austria suffers from some form of IBS - therefore around one million people in all. Using currently available techniques, it is only possible to diagnose IBS by a process of elimination.
Roark Capital Group, an Atlanta-based private equity firm, announced today that its affiliates have acquired Atkins Nutritionals, a leading international weight control and nutrition brand. Atkins' management team, led by CEO Monty Sharma, will remain with the business and invested alongside Roark Capital in the transaction. Terms of the transaction were not released.
New research by the Gladstone Institutes of Cardiovascular Disease (GICD) and the University of California, San Francisco (UCSF), has revealed the genetic determinants of fat storage in cells, which may lead to a new understanding of and potential treatments for obesity, diabetes, and heart disease. While scientists have long understood that lipid droplets contribute to fat build up in cells, the genes involved in droplet biology have been a focus of extensive research.
› Verified 6 days ago
Dr. Thomas Parsley, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 161 Riverside Dr, Suite 306, Binghamton, NY 13905 Phone: 607-798-6700 Fax: 607-798-6745 | |
Purushothaman Muthukanagaraj, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1042 Mitchell Ave # 42, Binghamton, NY 13903 Phone: 607-762-2990 | |
Ali Marhaba, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 40 Mitchell Ave, Binghamton, NY 13903 Phone: 607-772-0639 | |
Kiran Talati, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 20-24 S Washington St, Binghamton, NY 13903 Phone: 607-772-6161 Fax: 607-772-6138 | |
Leslie Bank, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 40 Mitchell Ave, Binghamton, NY 13903 Phone: 607-772-0639 | |
Dr. Stephen Francis Kucera, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3248 Dogwood Dr, Binghamton, NY 13903 Phone: 607-722-9352 |